LENZ Therapeutics (LENZ) Prepaid Assets (2020 - 2026)
LENZ Therapeutics (LENZ) posted quarterly Prepaid Assets of $6.1 million for Q1 2026, up 62.93% year-over-year from $3.8 million in Q1 2025, and up 5.88% quarter-over-quarter from $5.8 million in Q4 2025.
LENZ Therapeutics (LENZ) Prepaid Assets (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has reported Prepaid Assets for 7 consecutive years, with $6.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 62.93% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 62.93% YoY), while the FY2025 annual figure was $5.8 million, up 109.16% from the prior year.
- Prepaid Assets rose to $6.1 million in Q1 2026 per LENZ's latest filing, from $5.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.1 million in Q4 2022 and bottomed at $181000.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $3.7 million across 5 years, with a median of $3.5 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets slumped 93.14% — and 2023, when it surged 1490.06%.
- LENZ Therapeutics' Prepaid Assets stood at $7.1 million in 2022, then sank by 79.68% to $1.4 million in 2023, then surged by 91.24% to $2.8 million in 2024, then surged by 109.16% to $5.8 million in 2025, then increased by 5.88% to $6.1 million in 2026.
- Business Quant data shows LENZ's Prepaid Assets at $6.1 million in Q1 2026, $5.8 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | LENZ Therapeutics | 147.30 Mn | 147.30 Mn | 5.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.72 Mn |
| Mar 31, 2026 | 6.14 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 2.88 Mn |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 4.57 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 6.28 Mn |